Cargando…
Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2–3: A narrative review
Current management of Cervical Intraepithelial Neoplasia (CIN), caused by high-risk human papillomavirus (hr-HPV), is based on surveillance and surgical therapy. Procedures carry potential risks such as preterm birth, and access remains limited throughout the world. However, there are no medical the...
Autores principales: | Desravines, Nerlyne, Miele, Kate, Carlson, Rebecca, Chibwesha, Carla, Rahangdale, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356206/ https://www.ncbi.nlm.nih.gov/pubmed/32685652 http://dx.doi.org/10.1016/j.gore.2020.100608 |
Ejemplares similares
-
Pathways of IFN-alpha Activation in Patients with Cervical Intraepithelial Neoplasia (CIN)
por: Tirone, Nelson Ranieri, et al.
Publicado: (2021) -
Acute anterior uveitis after topical interferon for conjunctival intraepithelial neoplasia (CIN)
por: Naravane, Ameay V., et al.
Publicado: (2021) -
Development and Validation of a Raman Spectroscopic Classification Model for Cervical Intraepithelial Neoplasia (CIN)
por: Traynor, Damien, et al.
Publicado: (2022) -
Dysbiotic Co-Factors in Cervical Cancer. How the Microbiome Influences the Development of Cervical Intraepithelial Neoplasia (CIN)
por: Finzer, Patrick, et al.
Publicado: (2023) -
High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling
por: Øvestad, Irene Tveiterås, et al.
Publicado: (2021)